The FDA Approves Eli Lilly's Onswik (Insulin Efsitora Alfa-gobe) For Type 2 Diabetes
Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin efsitora alfa-gobe), a once-weekly basal insulin, indicated along with diet and exercise to control high
Eli Lilly got government permission to sell a new insulin medicine. When companies launch new products that doctors can prescribe, it shows they are growing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.